BRCA2 and prostate carcinoma: The higher risk and possible predisposition to aggressive disease is similar to the risk of prostate cancer associated with pathogenic variants in BRCA2.9, 25 A confirmed risk of prostate cancer in men with mismatch repair pathogenic variants would offer the opportunity for targeted screening to enable earlier detection.